Comparison Of Efficacy Of Tazarotene 0.045% Vs Halobetasol Propionate 0.01% Lotion For Treatment of Scalp Psoriasis
Condition: Scalp Psoriasis Intervention: Drug: Tazarotene 0.045% Topical Application Lotion [ARAZLO] Sponsor: Jinnah Postgraduate Medical Centre Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis Who Need Treatment for Repeated Flares
Condition: Generalized Pustular Psoriasis Intervention: Drug: Spesolimab Sponsor: Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2023 Category: Research Source Type: clinical trials